The meeting and exposition will be held from December 7th through the 10th. Deutsche Bank analyst James Shin has lowered his ...

Headquartered in Indianapolis, Indiana, Eli Lilly and Company (LLY) is a leading biopharmaceutical firm with a market cap of ...

Tesla remains a significant holding for The Future Fund despite position reductions, according to Managing Partner Gary Black ...

We recently compiled a list of the 10 Best Low Volatility Stocks to Invest in Now. In this article, we are going to take a ...

Deutsche Bank lowered the firm’s price target on Eli Lilly (LLY) to $1,015 from $1,025 and keeps a Buy rating on the shares following the ...

It's shaping up to be a tough period for Eli Lilly and Company , which a week ago released some disappointing third-quarter ...

Deutsche Bank analyst James Shin lowered the firm’s price target on Eli Lilly (LLY) to $1,015 from $1,025 and keeps a Buy rating on the shares. Following the Q3 earnings report, it wouldn’t be ...

On Thursday, Truist Securities adjusted its stock price target for Eli Lilly (NYSE:LLY) shares, bringing it down slightly to $1,029 from the previous $1,033 while still maintaining a Buy rating on ...

Eli Lilly and Company (NYSE:LLY – Free Report) had its price target hoisted by Citigroup from $1,060.00 to $1,250.00 in a research note issued to investors on Friday morning, Benzinga reports.

For Q3 2024, Aristotle Atlantic’s Large Cap Growth Composite posted a total return of 1.26% gross of fees, underperforming ...

One big idea has loomed over healthcare stocks over the past two years: Demand for the new GLP-1 weight loss medicines from ...